What the Study Says
Are GLP-1 weight loss drugs a medical miracle or a ticking time bomb for your pancreas? In this deep dive, we bypass the sensationalized media headlines and government warnings to uncover the raw, peer-reviewed data on the GLP-1 pancreatitis risk. We explore groundbreaking research like the SURMOUNT-1 and SELECT trials to reveal how popular medications like Mounjaro, Ozempic, and Wegovy actually lower systemic inflammation and provide unprecedented cardiovascular benefits. Discover the truth about healing metabolic decline, separating media fear from medical facts, and what this new era of metabolic endocrinology means for your long-term health and weight loss journey. Watch on YouTube with subtitles: https://www.youtube.com/@whatthestudysays [https://www.youtube.com/@whatthestudysays] Podcast: https://podcasts.apple.com/tw/podcast/what-the-study-says/id1814559387 [https://podcasts.apple.com/tw/podcast/what-the-study-says/id1814559387] FLink: https://open.firstory.me/user/cmao5odis0eyf01w36mahd8ub/platforms [https://open.firstory.me/user/cmao5odis0eyf01w36mahd8ub/platforms] Tell us what you think: https://open.firstory.me/user/cmao5odis0eyf01w36mahd8ub/comments [https://open.firstory.me/user/cmao5odis0eyf01w36mahd8ub/comments] Powered by Firstory Hosting [https://firstory.me/zh]
100 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de What the Study Says!